Search Results
Sep 30, 2025, 12:00 ET Cisco Unveils Advanced AI-Powered Webex Contact Center Solutions and Industry Integrations
SAN JOSE, Calif., Sept. 30, 2025 /PRNewswire/ -- Cisco (NASDAQ: CSCO) today
More news about: Cisco Systems, Inc.
Sep 30, 2025, 12:00 ET Cisco Introduces Agentic Capabilities for Next-Generation Collaboration
SAN JOSE, Calif., Sept. 30, 2025 /PRNewswire/ -- Today at WebexOne 2025, Cisco (NASDAQ: CSCO) unveiled
More news about: Cisco Systems, Inc.
Sep 25, 2025, 09:37 ET The FDA Granted Orphan Drug Designation to Biostar Pharma's Utidelone for the Treatment of Pancreatic Cancer
effect, and the combination demonstrates stronger anti-tumor activity compared with the traditional paclitaxel plus gemcitabine regimen. At the 2024 CSCO Annual Meeting, Biostar presented preliminary results from a multicenter, single-arm Phase II clinical study evaluating Utidelone combined with gemcitabine
More news about: Biostar Pharma, Inc.
Sep 22, 2025, 22:56 ET Ivonescimab HARMONi-6 Results Selected for ESMO 2025 LBA; Final Phase III Results of Cadonilimab as First-Line Therapy for Advanced Gastric Cancer to Be Published as an Oral Presentation
gastric cancer. Furthermore, the regimen was included as the only immunotherapy strategy with a Category I Recommendation (Level IA Evidence) in the 2025 CSCO Gastric Cancer Guidelines, facilitating its widespread adoption in clinical practice. Forward-Looking Statement of Akeso, Inc. This
More news about: Akeso, Inc.
Sep 16, 2025, 09:00 ET AI Workforce Consortium Finds 78% of ICT Roles Now Include AI Technical Skills, While Human Skills Gain Priority for Responsible Tech Adoption
its second study, "ICT in Motion: The Next Wave of AI Integration," which finds that AI roles now dominate tech market growth. Led by Cisco (NASDAQ: CSCO), the Consortium is a private sector collaboration that includes industry leaders Accenture, Cornerstone, Eightfold AI, Google, IBM, Indeed, Intel, Microsoft
More news about: Cisco Systems, Inc.
Sep 15, 2025, 12:00 ET MEDIA ALERT: Cisco's WebexOne Event Spotlights Global AI Brands and Ryan Reynolds, Acclaimed Actor, Film Producer, and Entrepreneur
SAN JOSE, Calif., Sept. 15, 2025 /PRNewswire/ -- Cisco (NASDAQ: CSCO) today announced its luminary customers and partners headlining
More news about: Cisco Systems, Inc.
Sep 10, 2025, 10:00 ET Alcott Global Reveals Top 30 Supply Chain Leaders of 2025
chain sector: Mourad Tamoud, CSCO, Schneider Electric (2023–2024 Award Winner)Michael Corbo, Former CSCO, Colgate-PalmoliveKai Hoberg, Professor, SCM, Kühne Logistics UniversityCheryl Capps, Former CSCO, CorningKnut Alicke,
More news about: Alcott Global
Sep 09, 2025, 08:30 ET Cisco Elevates the SOC with Agentic AI for Faster Threat Response and Reduced Complexity
newsroom. Availability dates and regions are subject to change. About Cisco Cisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco
More news about: Cisco
Sep 09, 2025, 08:30 ET Cisco Supercharges Observability with Agentic AI for Real-Time Business Insights
and innovation. The timeline for their release is subject to change. About Cisco Cisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco
More news about: Cisco Systems, Inc.
Sep 08, 2025, 18:00 ET Cisco Advances Open Data Ecosystems with Splunk Federated Search for Snowflake
newsroom. Availability dates and regions are subject to change. About Cisco Cisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco has
More news about: Cisco Systems, Inc.
Sep 08, 2025, 18:00 ET Cisco Data Fabric Transforms Machine Data into AI-Ready Intelligence
newsroom. Availability dates and regions are subject to change. About Cisco Cisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco
More news about: Cisco Systems, Inc.
Sep 08, 2025, 09:30 ET Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market
highlighted clinical data from multiple oncology studies at the 2025 World Conference on Lung Cancer and CSCO Annual Meeting, showcasing updated analysis from savolitinib's SACHI, SAVANNAH and Phase IIIb confirmatory studies in non-small cell lung cancer patients.
More news about: USA News Group
Sep 04, 2025, 09:00 ET Cisco Secure AI Factory with NVIDIA Unlocks Enterprise Data for Agentic AI
SAN JOSE, Calif., Sept. 4, 2025 /PRNewswire/ -- Cisco (NASDAQ: CSCO) today unveiled a solution for building AI infrastructure designed to support workload data fabrics, further enabling enterprises to securely use their
More news about: Cisco Systems, Inc.
Sep 02, 2025, 16:30 ET Cisco to Participate in September 2025 Events with the Financial Community
SAN JOSE, Calif., Sept. 2, 2025 /PRNewswire/ -- Cisco (NASDAQ: CSCO) will participate in the following events with the financial community in September:
More news about: Cisco Systems, Inc.
Aug 22, 2025, 08:00 ET Cisco to Participate in August 2025 Deutsche Bank Technology Conference
SAN JOSE, Calif., Aug. 22, 2025 /PRNewswire/ -- Cisco (NASDAQ: CSCO) will participate in the 2025 Deutsche Bank Technology Conference.
More news about: Cisco Systems, Inc.
Aug 13, 2025, 16:05 ET CISCO REPORTS FOURTH QUARTER AND FISCAL YEAR 2025 EARNINGS
refer to the Form 8-K regarding this release furnished today to the Securities and Exchange Commission. About Cisco Cisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco has
More news about: Cisco Systems, Inc.
Aug 05, 2025, 08:00 ET Cisco Reinvents Digital Resilience for the Agentic Era at Splunk .conf25
Splunk .conf25 website. About Cisco Cisco (NASDAQ: CSCO) is the worldwide technology leader that is revolutionizing the way organizations connect and protect in the AI era. For more than 40 years, Cisco has
More news about: Cisco Systems, Inc.
Aug 04, 2025, 08:00 ET Cisco Schedules Conference Call for Q4 Fiscal Year 2025 Financial Results
SAN JOSE, Calif., Aug. 4, 2025 /PRNewswire/ -- Cisco (NASDAQ: CSCO) has scheduled a conference call for Wednesday, Aug 13, 2025, at 1:30 PM (PT); 4:30
More news about: Cisco Systems, Inc.
Jun 30, 2025, 16:05 ET Cisco & Wells Fargo to Host Silicon One Tech Talk
SAN JOSE, Calif., June 30, 2025 /PRNewswire/ -- Cisco (NASDAQ: CSCO) will host a Tech Talk to discuss Silicon One. The session will be led by Martin Lund, EVP, Common Hardware Group, and
More news about: Cisco Systems, Inc.
Jun 24, 2025, 05:29 ET Accord Healthcare recibe la aprobación para Hetronifly® de la MHRA para el tratamiento de ES-SCLC
Además, serplulimab fue recomendado por las Guías de CSCO para el Cáncer de Pulmón de Células Pequeñas, las Guías de CSCO para el Cáncer de Pulmón de Células No Pequeñas, las Guías de CSCO para el Cáncer de Esófago, las Guías de Práctica Clínica de CSCO sobre Inhibidores de Puntos de Control Inmunitario,
More news about: Accord Healthcare
Jun 24, 2025, 02:00 ET Accord Healthcare receives approval for Hetronifly® (Serplulimab), from the Medicines and Healthcare Regulatory Agency (MHRA) for first-line treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Cancer, respectively. Furthermore, serplulimab was respectively recommended by the CSCO Guidelines for Small Cell Lung Cancer, the CSCO Guidelines for Non-Small Cell Lung Cancer, the CSCO Guidelines for Esophageal Cancer, the CSCO Clinical Practice Guidelines on Immune Checkpoint Inhibitor, the China Guidelines
More news about: Accord Healthcare
Jun 24, 2025, 02:00 ET Accord Healthcare erhält die Zulassung für Hetronifly® (Serplulimab) von der Medicines and Healthcare Regulatory Agency (MHRA) für die Erstlinienbehandlung von kleinzelligem Lungenkrebs im Extensivstadium (ES-SCLC)
British Journal of Cancer veröffentlicht. Darüber hinaus wurde serplulimab in den CSCO Guidelines for Small Cell Lung Cancer, den CSCO Guidelines for Non-Small Cell Lung Cancer, den CSCO Guidelines for Esophageal Cancer, den CSCO Clinical Practice Guidelines on Immune Checkpoint Inhibitor, den China Guidelines
More news about: Accord Healthcare
Jun 24, 2025, 02:00 ET Accord Healthcare reçoit l'approbation de la Medicines and Healthcare Regulatory Agency (MHRA) pour Hetronifly® (Serplulimab), pour le traitement de première ligne du cancer du poumon à petites cellules au stade extensif (ES-SCLC).
of Cancer, respectivement. En outre, le serplulimab a été recommandé par les CSCO Guidelines for Small Cell Lung Cancer, les CSCO Guidelines for Non-Small Cell Lung Cancer, les CSCO Guidelines for Esophageal Cancer, les CSCO Clinical Practice Guidelines on Immune Checkpoint Inhibitor, les China Guidelines
More news about: Accord Healthcare
Jun 12, 2025, 16:00 ET Cisco & JP Morgan to Host Innovation Tech Talk
SAN JOSE, Calif., June 12, 2025 /PRNewswire/ -- Cisco (NASDAQ: CSCO) will host a Tech Talk to discuss innovation at Cisco. The session will be led by Jeetu Patel, President and Chief Product
More news about: Cisco Systems, Inc.
Jun 11, 2025, 07:46 ET Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand
and President of Cancer Hospital Chinese Academy of Medical Sciences Henan Hospital, as well as Chairman of the Chinese Society of Clinical Oncology (CSCO) Radiation Therapy Committee; and Dr. Tao Yong, Director of the Ophthalmology Department at Beijing Chao-yang Hospital, Capital Medical University
More news about: Ping An Healthcare and Technology Company Limited